The innate immune system serves as the first line of defense to protect the host from pathogen infection. As a first step, the pattern recognition receptors (PRRs) recognize pathogen-associated molecular patterns (PAMPs), such as non-self DNA derived from pathogens, and damage-associated molecular patterns (DAMPs), such as self DNA released from damaged or injured cells. Sensing of such DNAs elicits innate immune responses through the production of type I interferons (IFNs) and proinflammatory cytokines resulting from the activation of interferon regulatory factor 3 (IRF3) and nuclear factor kappa B (NF-κB), respectively. These cytokines are key players in interlinking innate and adaptive immune responses. However, defects in DNA sensors and their signaling cascades lead to dysregulation of immune responses, autoimmune diseases, and cancer progression. Here we provide an update on DNA signaling pathways in response to pathogen infection and cell injury, and on the roles of regulators in governing the immune system and maintaining host homeostasis. We also discuss the evasion of immunosurveillance by pathogens.
I. INTRODUCTION
Mammalian immunity is governed by two major immune systems-innate and adaptive-which are mandatory to respond against pathogen invasions and maintain host homeostasis. The innate immune system is an inherent defense system and serves as the first line of defense to detect pathogen intrusion via pattern recognition receptors (PRRs). PRRs recognize pathogen-associated molecular patterns (PAMPs) derived from pathogens and also damage-associated molecular patterns (DAMPs) that are released from host cells following cellular damage or cellular stress. Binding of such molecular patterns to PRRs activates corresponding signaling cascades and induces production of inflammatory cytokines and type I interferons (IFNs), which are key players in activating subsequent immune responses. On the other hand, the adaptive immune system is an antigen-specific response and stimulates a long-lasting immune memory that depends on T and B lymphocytes that possess rearranged gene segments. 1 While non-self DNAs, such as from pathogens, are critical stimulators of innate immune responses to eliminate pathogens, self DNAs also activate host immune responses. As an example that is beneficial to the host, damaged self DNA released from post-chemotherapy cancer cells have been suggested to be important in driving immune-mediated tumor destruction. [2] [3] [4] However, aberrant leakage or dysregulated release of self DNA or mitochondrial DNA from damaged cells, as well as dysregulated host immune responses against such DNAs, lead to autoimmune diseases. 5, 6 Among the innate PRRs, Toll-like receptor 9 (TLR9), which localizes in the endosome, was the first PRR discovered to recognize extracellular DNA. 7 Other identified DNA sensors are present in the cytosol to detect free intracellular DNA. 8, 9 These include DNA-dependent activator of IFN-regulatory factors (DAI), 10 RNA polymerase III, 11, 12 DExD/ H-box helicases (DHX9 and DHX36), 13 DEAD-box helicase 41 (DDX41), 14 DNA-dependent protein kinase (DNA-PK), 15 absent in melanoma 2 (AIM2), 16 interferon-g-inducible protein 16 (IFI16), 17 meiotic recombination 11 homolog A (MRE11), 18 and cyclic GMP-AMP synthase (cGAS). 19 Activation of these DNA sensors and their downstream signaling cascades results in the induction of inflammatory cytokines and type I interferon (IFN) production following activation of nuclear factor kappa B (NF-kB) and interferon regulatory factor (IRF) transcription factors, respectively, and the induction of subsequent inflammatory responses. 8, 9 However, aberrant regulation in DNA-sensing mechanisms is suggested to lead to autoimmune diseases. Therefore, comprehensive understanding of DNA-sensing mechanisms should lead to an understanding of autoimmune diseases caused by aberrance in these sensing mechanisms as well as immune responses against pathogen infection. In this review, we discuss DNA-sensing pathways and their regulators, how they modulate signaling cascades, how the evasion of immunosurveillance by pathogens takes place, and the disorders resulting from DNA-sensing pathway dysregulation.
II. DNA SENSORS

A. TLR9: Endosomal DNA Sensor
TLRs are type I transmembrane proteins. They consist of an extracellular domain with leucine-rich repeats and a cytoplasmic domain homologous to that in human interleukin (IL)-1 receptor, which is known as the Toll/IL-1R (TIR) domain. 20, 21 TLRs can be classified depending on their localization as cell surface or endosomal. Cell surface TLRs include TLR1, TLR2, TLR4, TLR5, and TLR6, which recognize lipoproteins, lipids, and proteins. On the other hand, TLR3, TLR7, TLR8, and TLR9 are localized in the endosome and sense nucleic acids. [21] [22] [23] Each of these TLRs has a pivotal role in eliciting innate immune responses against different PAMPs derived from pathogens such as bacteria, virus, fungi, and parasites.
TLR9 is known as a DNA sensor. 7, 8, 24 Upon binding with the unmethylated cytosine-phosphate-guanine (CpG) motif (no methylation at the CG sequence) of non-self DNA, two TLR9-CpG DNA complexes form the dimeric structure, in which CpG DNA is recognized by two leucine-rich-repeat (LRR) promoter regions, LRRNT-LRR10 and LRR20-LRR22) in each TLR9. 25 The degradation of DNA in endosomes results in DNA fragment formation, and only unmethylated DNA fragments with more than 21 nucleotides can robustly activate TLR9 response. 26 Synthetic oligodeoxynucleotides (ODNs) making up the unmethylated CpG motif that mimicks the CpG motif of pathogens have been used as TLR9 activators. 26, 27 Pohar et al. suggested that activation of TLR9 by ODNs is enhanced in the presence of CpG-containing ODNs as short as two nucleotides.
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TLR9 is an endosomal TLR originally situated on the endoplasmic reticulum (ER) of human immune cells-predominantly plasmacytoid DCs and B-cells. 29 It is also expressed in human natural killer cells. 30 Upon CpG DNA stimulation, the DNA is transported into the early endosome and followed by lysosomal compartment. 31 In the endolysosome, the ectodomain of TLR9 undergoes proteolytic cleavage by asparagine endopeptidase and cathepsin to generate a functional receptor for DNA sensing and stimulates downstream signaling. [32] [33] [34] The trafficking of TLR9 from the endosomal compartment to a specialized lysosome-related organelle by adapter protein 3 (AP-3) is important for type I IFN production but not for proinflammatory cytokine production [ Fig. 1(1) ]. 35 Chaperone protein UNC93B1 localized in the ER membrane also plays important 
FIG. 1:
Intracellular DNA-sensor signaling pathways. DNA from pathogens such as retrovirus, virus, and bacteria, as well as self DNA, resulting from damaged mitochondria can be sensed by DNA sensors. Activation of these sensors roles in trafficking and localizing of endosomal TLRs, including TLR9, for functional signaling pathways. 36 A single-point mutation of UNC93B1 limits interaction between the protein and TLR9 and thereby abolishes downstream signaling activation in splenocytes and DCs. 37, 38 TLR9 activation can initiate two distinct pathways: NF-kB-mediated proinflammatory cytokines and IRF7-dependent type I IFN production. 35 Recognition of CpG DNA by TLR9 recruits myeloid differentiation factor 88 (MyD88) adaptor protein that further forms a Myddosome complex together with IL-1R-associated kinases (IRAKs) [ Fig. 1(1) ]. 39 TNF receptor associated factor 6 (TRAF6) is then recruited to the complex and induces K63-linked auto-ubiquitination as well as ubiquitination of I kappa B kinase (IKK) g (also known as NEMO, which stands for NF-kB essential modulator) to activate IKKs. 40, 41 The IKK complex comprises two catalytic subunits, IKKa and IKKb, and a regulatory subunit, IKKg. The binding to IKKg of linear ubiquitin chains formed by linear ubiquitin chain assembly complex (LUBAC) drives the TGF beta-activated kinase 1 (TAK)-mediated phosphorylation of IKKa and IKKb to prime IKKb autophosphorylation. 42 The activated IKKs phosphorylate IkBa and trigger its proteasomal degradation to allow nuclear translocation of NF-kB. 8, 21, 23, 43 The proteolytically cleaved TLR9 in the NF-kB endosome interacts with AP-3 to facilitate its trafficking to lysosome-related organelles. 35 Translocation of cleaved TLR9 to the CpG-containing lysosomal compartment stimulates IFN-a production FIG. 1: (continued) promotes their downstream signaling cascades to signal type I IFN production as well as activation of NF-kB and IRF3 transcription factor. (1) TLR9 signaling. The inactivated form of TLR9 localizes on the membrane of the ER and translocates to the membrane of the endosome or the LRO with the aid of UNC93B1 and AP-3 in response to stimuli. TLR9 activates NF-kB signaling through the MyD88-dependent pathway via the IRAKs-TRAF6-TAK1 axis. Translocation of cleaved TLR9 from the endosome to the LRO stimulates type I IFN production through the MyD88-IRAK-1-TRAF6-TRAF3-IRF7 axis. Viperin recruits IRAK1 and TRAF6 to lipid bodies to mediate the IRAK1 ubiquitination. OPN is recruited to stabilize TRAF3 via direct binding to TRAF3. (2) DNA sensor inflammasomes: AIM2 and IFI16. Upon exposure to intracellular DNA, ASC and pro-caspase-1 are recruited to the stimulated AIM2 or IFI16. AIM2 recognition depends on STING-dependent type I IFN. IFI16 recruits the STING adaptor protein and TBK1 to trigger transcription factors IRF3 and NF-kB as well as IFN-b production. (3) cGAS. cGAS activated by DNA synthesizes a second messenger, cGAMP. Stimulated cGAS synthesizes cGAMP, which is recognized by STING. This is followed by translocation of STING from the ER to the Golgi apparatus prior to interaction with the TBK1 located on perinuclear vesicles. This induces STING-dependent IRF3 activation and resultant type I IFN production. Activated IKKβ is crucial for subsequent NF-kB and TBK1-IRF3 signaling. TBK1 is also an important regulator of full induction of IKKβ through phosphorylation. through MyD88-IRAK-1-TRAF6-IRF7. 24, 31 The Myddosome complex interacts with TRAF6 to induce K63-linked polyubiquitination of IRF7. 24, 44 Viperin recruits IRAK1 and TRAF6 to the lipid bodies to mediate IRAK1 ubiquitination for IRF7 translocation in plasmacytoid DCs. 23, 45 TRAF3 is an essential component in the stimulation of type I IFN production. 35, 46 Osteopontin is necessary to stabilize TRAF3 via direct binding to TRAF3 and abolishes the E3 ubiquitin ligase Triad3A-mediated degradation of TRAF3, followed by stimulation of IFN-b production in response to viral infection. 47 Defective osteopontin fails to drive the IRF7 translocation to the nucleus for transcription of type I IFN genes in plasmacytoid DCs. 48, 49 In addition, AP-3 facilitates interaction between TRAF3 and IRF7. 35 IKKa also plays an important role by binding to IRF7 and inducing its phosphorylation. Inflammasome is a multiprotein complex involved in the inflammatory pathway that relies on the detection of PAMPs and endogenous molecules in the cytosol. It comprises a PRR, the apoptosis-associated speck-like protein containing a CARD (ASC), and the caspase-1 effector protein. 16 Intracellular DNAs are sensed by AIM2 or IFI16 at their HIN200 domains to recruit ASC, followed by caspase-1 to form inflammasomes [ Fig.1(2) ]. 16, 51 Inflammasome formation promotes proteolytic cleavage and activation of caspase-1, which subsequently cleaves pro-IL-1β and pro-IL-18 into the activated form of IL-1β and IL-18, respectively. 52, 53 This event leads to the release of biologically active cytokines (IL-1β and IL-18) and pyroptosis, an emerging type of programmed cell death. 54 The AIM2 inflammasome is crucial to responses against intracellular DNA viruses and bacteria. 55 Following Francisella novicida infection, the DNA sensor cGAS (which is described in detail later) senses the infection and its adaptor STING orchestrates the expression of type I IFN-IRF1-dependent guanylate-binding proteins (GBPs). 56, 57 The expression of GBPs, which include GBP2 and GBP5, results in intracellular lysis of bacteria and subsequent liberation of bacterial DNA into the cytosol, and presents the bacteria ligands to be sensed by AIM2, which triggers inflammasome formation. 56, 58 Although Chlamydia trachomatis cyclic di-AMP also triggers the activation of the AIM2 inflammasome, the STING-type I IFN signaling pathway, but not cGAS, is suggested to be required for AIM2 activation. 59 Similarly, the DNA of Brucella abortus and murine cytomegalovirus can be sensed by AIM2 through localizing with AIM2 depending on STING-dependent type I IFN. [60] [61] [62] Upon Legionella pneumophila infection, the AIM2 inflammasome induced caspase-induced pore formation that resulted in potassium (K+) efflux-mediated activation of noncanonical NLRP3. 63 Furthermore, human monocytes and THP-1 cells specifically activated AIM2 inflammasome and released caspase-1-dependent IL-1b during EpsteinBarr virus infection. 64 AIM2 inflammasome also has a role in governing IRF3-activated innate immune responses in the RAW264.7 cell line following recombinant adenoviral vector infection. 65 During modified vaccinia Ankara viral and Francisella tularensis subsp. novicida bacterial infections, the role of AIM2 in DNA inflammasome is substituted by NLRP3 in primary human myeloid cells, but not in THP-1 cells. 66 Lysosomal cell death occurs after sensing of non-self DNA by the cGAS-STING signaling pathway and triggers K + efflux followed by activation of NLRP3 inflammasome without AIM2 involvement. 66 In low basal IFI16 expression, DDX41 is a primary DNA sensor that recognizes intracellular DNA to induce type I IFN production followed by enhanced IFI16 expression.
14 It has been revealed that IFI16 regulates innate immune responses by triggering cGAS activity [ Fig. 1(2) ]. Following recognition of intracellular viral DNA by direct binding to it, IFI16 further recruits the STING adaptor protein and TBK1 to trigger transcription factor IRF3 and NF-kB as well as IFN-b production. 17, 67 Together with cGAS, IFI16 plays an important role in sensing DNA damage to prime the STING-induced type I IFN production for robust antimicrobial response. 68 . Studies indicate that multiple DNA-sensing pathways can cooperate with one another to induce inflammatory responses.
C. cGAS-STING Signaling Pathway:
Intracellular DNA Sensor cGAS and STING are constitutively expressed in DCs and macrophages. 69 In 2013, Sun et al. identified cGAS as a DNA sensor that produces cyclic GMP-AMP (cGAMP) from ATP and GTP as a second messenger. 19 DNA damage or chromosomal instability leads to micronuclei formation. It is reported that, upon the rupture of micronuclei, DNA content is accessible to cGAS, which subsequently activates proinflammatory signaling. 4 Structural analysis revealed that cGAS selectively binds to B-form double-stranded DNA (dsDNA). 70 cGAS's two DNA binding sites detect short DNA with less than 20 base pairs. 71 In contrast, Luecke et al. suggested that long DNA with 4,003 base pairs can activate cGAS more efficiently in low concentrations. 72 Higher concentrations of DNA induce substrate exhaustion, which may be the reason that the proposed 20-base-pair short DNA's efficiency is comparable to that of ~1,000-base-pair DNA in synthesizing cGAMP. 72 Following the binding of DNA to cGAS, the activation loop of cGAS is activated and forms a dimerization structure [ Fig. 1(3) ]. 73 It is reported that the dimerization of cGAS and DNA binding activity is facilitated by a tripartite motif containing (TRIM) 56, an E3 ubiquitin ligase that induces monoubiquitination of cGAS at Lys335 (Fig. 2) . 74 Meanwhile, the stability of cGAS is regulated by TRIM14 through recruitment of ubiquitin-specific protease 14 (USP14) to cleave the K48-linked polyubiquitin chains on cGAS, which promotes its autophagic degradation (Fig. 2) . 75 The stimulated cGAS synthesizes cGAMP, which further induces STINGdependent IRF3 activation and resultant type I IFN production. 19, 76 STING, also known as MITA, ERIS, or TMEM173, is the central adaptor protein in DNAsensing pathways that facilitates the initiation of NF-kB and IRF3/7 signaling cascades. 77 Upon exposure to intracellular DNA, K63-linked polyubiquitination on STING by E3 ubiquitin ligase TRIM32 and TRIM56 promotes dimerization of STING (Fig.  2) . 78, 79 The stability of the STING structure is governed by RING finger protein (RNF) 26, which induces post-translational modification of STING through K11-linked polyubiquitination (Fig. 2) . 80 After sensing intracellular DNA, STING translocates from the ER to TBK1, located on perinuclear vesicles, through the Golgi apparatus; following this is the production of type I IFNs, such as IFN-a and IFN-b, and proinflammatory cytokines. 81, 82 Recently Wang et al. reported that S6K1 associates with STING to induce TBK1 recruitment, in which the S6K1-STING-TBK1 complex is required for IRF3 activation (Fig. 2) . 83 
Positive Regulators of the cGAS-STING Axis
The cGAS-STING axis is regulated by positive regulators (Fig. 2 ). For instance, K63-linked auto-polyubiquitination of the TRIM9 short isoform (TRIM9s) promotes binding of GSK3β to TBK1 for subsequent TBK1 oligomerization and autophosphorylation, resulting in activation of its downstream IRF3 transcription factor. 84, 85 On the other hand, TRIM9s specifically inhibits proinflammatory cytokines by preventing IkB degradation in NF-kB signaling.
84 TRIM32 and TRIM56 are also reported to induce K63-linked polyubiquitination of IKKγ, thereby activating IKKβ, which is crucial for subsequent NF-kB and TBK1-IRF3 signaling activation. TBK1 is also an important regulator of full induction of IKKβ activation through its phosphorylation. 86 Shang et al. identified TTC4 as a positive regulator of TBK1 and reported that its interaction with TBK1 during Sendai virus infection elicited IRF3 activation and IFN-b1 production. 87 Also, E3 ubiquitin ligases such as RNF185 can associate with cGAS directly during herpes simplex virus 1 (HSV-1) infection to catalyse cGAS K27-linked polyubiquitination for promoting cGAS enzymatic activity. 88 
Negative Regulators and Inhibitors of the cGAS-STING Axis
Negative regulators in DNA-sensing machinery are indispensable in preventing excessive and detrimental inflammatory responses and maintaining host homeostasis. In particular, because STING is the key molecule involved in various DNA-sensing
Positive regulators of the cGAS-STING signaling pathway. E3 ubiquitin ligases such as RNF185 associate with cGAS directly to catalyse cGAS K27-linked polyubiquitination; TRIM56 induces monoubiquitination of cGAS for promoting cGAS enzymatic activity. TRIM14 ensures cGAS stability by inhibiting its autophagic degradation. TRIM32 and TRIM56 promote dimerization of STING, while STING structure stability is governed by RNF26 through K11-linked polyubiquitination. S6K1 associates with STING to induce TBK1 recruitment, forming the S6K1-STING-TBK1 complex. TTC4 interacts with TBK1 to elicit IRF3 activity and IFNB1 production. K63-linked auto-polyubiquitination of TRIM9s promotes binding of GSK3β to TBK1 for subsequent TBK1 oligomerization and auto-phosphorylation, resulting in activation of its downstream IRF3 transcription factor. On the other hand, TRIM9s specifically inhibits proinflammatory cytokines by preventing IkB degradation in NF-kB signaling. Besides interacting mechanisms, its activity is modulated by a number of negative regulators (Fig. 3) . It is reported that autophagy-related gene proteins such as Atg9a and ULK1/Atg1 play a significant role in suppressing STING activity to prevent aberrantly sustained innate immune responses. The colocalization of Atg9a to STING limits STING's translocation from the Golgi apparatus to the cytoplasmic punctate structures, where it recruits TBK1, but not its translocation from the ER to the Golgi apparatus.
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In addition, ULK1/Atg1 induces STING phosphorylation to repress its downstream IRF3, but not NFkB, activation. 89 Furthermore, RNF5, a E3 ubiquitin ligase that localizes on mitochondria and the ER, was found to ubiquitinate STING for proteasomal degradation, leading to suppression of both IRF3 activation and IFN-b1 expression.
90 RNF26 also negatively regulates the STING signaling pathway by degrading IRF3 through its autophagic protein degradation machinery in the late stages of infection. 80 Interestingly, RNF26 can also act as a negative regulator of RNF5 to enhance STING activity in an early stage of infection by interfering with RNF5-induced K48-linked polyubiquitination on their common polyubiquitination binding target. 80 Evidence uncovered by Zhang et al. highlights crosstalk between DNA-sensing pathways. The nucleotide-binding, leucine-rich-repeat-containing protein NLRC3 is another negative regulator of STING. NLRC3 interferes with the binding of STING to TBK1 via binding to both proteins, hence blocking production of type I IFN. 91 Wang et al. proposed that caspase-1 released from the activated inflammasome binds to cGAS, restricting its downstream STING-IFN signaling by cleaving it. 92 Mitochondrial dynamics mediators are also involved in the activation of STING signaling pathway. 93 NLRP3 agonists, such as nigericin and ATP, inhibit STING and its downstream effector, IRF3, through mitochondrial fission regulated by the mitochondrial fission regulator TBC1D15 and the mitochondrial fusion regulator mitofusin 1 in a manner independent of NLRP3 and potassium efflux. 93 Disulphide-bond A oxidoreductase-like protein (DsbA-L), which is localized in the mitochondrial matrix, has been reported to be the key regulator in suppressing obesity-associated inflammation as well as insulin resistance by inhibiting the cGAS-cGAMP-STING signaling pathway stimulated by cytosolic mitochondrial DNA. 94 Viruses and bacteria sometime evade host innate immunity by suppressing the DNA-sensing pathways (Table 1) . Kim et al. reported that a protein from the human cytomegalovirus (HCMV), IE2 86kDa, modulates STING degradation and interrupts cGAMP-induced IFNB1 and CXCL10 expression. 95 Tegument protein UL82 from HCMV interferes with the STING-iRhom2-TRAP translocation complex to disrupt STING translocation from the ER to the perinuclear vesicles. 96 HCMV UL82 also interrupts the recruitment of TBK1 and IRF3 to STING. 96 Furthermore, HCMV US9 obstructs interaction between STING and TBK1 and prevents STING oligomerization by competitively binding to it. 97 The US9 protein also colocalizes with IRF3 in the cytosol to block the phosphorylation of IRF3 through its cytoplasmic domain. 97 The HSV-1 protein UL46 (also known as VP11/12) has been found to suppress transcription of STING and IFI16 by interacting with STING at its N-terminal and with TBK1 at its C-terminal, thus restricting type I IFN production. 98 Unlike UL46, HSV-1 UL24 prevents IFN-b and IL-6 production by inhibiting cGAS-STING-mediated promoter activation and the IFN-stimulatory DNA-induced axis, and inhibits NF-kB activation via binding to each Rel homology domain (RHD) of the NF-kB p65 and p50 subunits; in this way, it evades innate immune responses. 99 HSV-1 UL41 also helps HSV-1 escape from host immunosurveillance by degrading cGAS mRNA to disrupt the cGAS-STING signaling pathway via UL41 RNase activity. 100 Another HSV-1 
FIG. 3:
Negative regulators of the cGAS-STING signaling pathway. DsbA-L inhibits the cGAS-cGAMP-STING signaling pathway by maintaining mitochondrial integrity to prevent leakage of cytosolic mitochondrial DNA. NLRP3 agonists, such as nigericin and ATP, inhibit IRF3 through mitochondrial fission that is regulated by the mitochondrial fission regulator TBC1D15. Caspase-1 from inflammasome activation binds to cGAS to induce cGAS cleavage, which restricts its downstream STING-IFN signaling. RNF5, an E3 ubiquitin ligase, ubiquitinates STING for proteasomal degradation, leading to suppression of IRF3 activation as well as IFNB1 expression. Colocalization of Atg9a to STING allows STING translocation from the Golgi apparatus to cytoplasmic punctate structures, where it recruits TBK1, but disallows its translocation from the ER to the Golgi apparatus. NLRC3 interferes the binding of STING with TBK1 via binding to both proteins. Phosphorylation of STING by ULK1 abrogates IRF3 activation. RNF26 also negatively regulates STING signaling pathway by degrading IRF3 through autophagic protein degradation machinery in the late protein, ICP27, has been reported to attenuate IRF3 activation by its interaction with STING-TBK1 signalsome in human macrophages. 101 Besides targeting the cGAS-STING axis, HSV-1 has a deubiquitinating enzyme, UL36USP, that abrogates NF-kB activation depending on its enzymatic activity through deubiquitinating IkBα to prevent it from undergoing proteasomal degradation. During hepatitis B virus invasion, the viral polymerase binds directly to STING and interferes with its K63-linked polyubiquitination, disrupting STING downstream IRF3 activation and IFN-b expression. 103 Furthermore, the protease cofactor of the dengue virus, NS2B, targets cGAS to induce lysosomal degradation, permitting evasion of mitochondrial DNA recognition by cGAS, which is supposed to be an important mechanism of response against cellular damage caused by dengue virus infection.
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D. Other DNA Sensors
The DNA-dependent activator of IFN-regulatory factors (DAI), also known as DLM-1/ZBP1, served as a DNA sensor via its three DNA-binding domains: Zα, Zβ, and D3 region. 10, 105 Upon sensing dsDNA, the activated DAI promotes interaction with TBK1 and IRF3 transcription factor [ Fig. 1(4) ]. 10 In addition to IRF3, DAI, through its RIP homotypic interaction motifs, induces NF-kB activation by recruiting two receptor-interacting proteins (RIPs), RIP1 and RIP3. Fig. 1(5) ].
11 IPS-1, also known as MAVS, VISA, and Cardif, contains an N-terminal CARDlike structure by which it binds to RIG-I or MDA5 through either's CARD domain, leading to the production of type I IFN via the IPS-1-TBK1-IRF3/7 axis. 107, 108 In myeloid DCs, DDX41 served as an intracellular dsDNA sensor binding to both DNA and STING to stimulate the STING-induced type I IFN cascade [ Fig. 1(6) ].
14 Silencing of DDX41 in bone marrow-derived macrophages abrogates poly(dA:dT)-induced IFN-b production and cGAS activation. 109 Bruton's tyrosine kinase (BTK) phosphorylates DDX41 at Tyr364 and Tyr414 to allow AT-rich DNA recognition, and it induces subsequent binding between STING and DDX41, leading to the induction of type I IFN.
110 DDX41-mediated immune signaling is negatively regulated by E3 ubiquitin ligase TRIM21, which promotes DDX41 degradation via K48-linked ubiquitination. 111 In plasmacytoid DCs, intracellular DHX36 and DHX9 sense CpG-A and CpG-B and directly associate with MyD88 to further induce IFN-a, TNF, and IL-6 production, following IRF7 nuclear translocation and NF-kB activation [ Fig. 1(7) ]. 13 DNA-PK was reported to be a PRR that participates in sensing intracellular DNA and stimulates type I IFN production via the STING-TBK1-IRF3 axis [ Fig. 1(8)] . 15 Deficiency of DNA-PKcs, which is a catalytic subunit of DNA-PK, in cells and in vivo mouse models, abolished cytokine responses upon DNA viral infection. 15 MRE11, which is present in both nucleus and cytoplasm, is another intracellular DNA sensor. It senses damaged intracellular DNA but not viral DNA. Together with its binding protein RAD50, MRE11 directly binds to the dsDNA in the cytoplasm, which induces activation of downstream the STING-TBK1-IRF3 axis in murine embryonic fibroblast and HeLa cells [ Fig. 1(9) ]. 18 Mutation of MRE11 was observed in a patient suffering from ataxia-telangiectasia-like disorder accompanied by defective dsDNA-induced type I IFN production.
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III. ROLE OF DNA-SENSING PATHWAYS
A. Antimicrobial Immunity DNA sensors are important in eliminating pathogens such as bacteria, viruses, and parasites during infection by recognizing microbial DNA (Table 2 ). TLR9 recognizes HSV-2 by plasmacytoid DCs through an endocytic pathway. 112 Moreover, it elicits innate immune responses against Aspergillus fumigatus,
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Helicobacter pylori, 114 Plasmodium falciparum, 115 Toxoplasma gondii, 116 murine cytomegalovirus, and HSV-1.
23 DDX41 and AIM2 DNA sensors have been reported to induce phosphorylation of IRF3 and subsequent type I IFN responses in the RAW264.7 mouse macrophage cell line following recombinant adenoviral vector infection. 65 Furthermore, DDX41, together with cGAS, has been found indispensable for type I IFN antiviral responses in murine leukemia virus DNA recognition. 117 Notably, DAI and its downstream molecules, such as RIP3 and STING, are constitutively expressed in glial cells such as microglia and astrocytes. Upon HSV-1 DNA stimulation, the expression of such molecules increases both in in vitro glial cells and in an HSV-1 encephalitis murine model; HSV-1 infection induces the production of neurotoxic mediators in a DAI-dependent manner. 118 Crill et al. further elucidated activation of glial inflammatory and antiviral responses against HSV-1 DNA via the activation of RIG-I and DAI in the presence of RNA polymerase III to elicit maximal antiviral responses. 119 Similarly, DAI plays a role in sensing HSV-2, in addition to TLR9 and IFI16 (to a lesser extent), via production of cytokines in vaginal cells. 120 Although HCMV possesses a protein that aids in evading immune response, the DNA sensor DAI, the expression of which is induced by HCMV infection, controls the replication of HCMV by promoting IRF3 activation and IFN-b expression in a STING-dependent and IPS-1-independent manner. 121 Paijo et al. reported the importance of cGAS in sensing the HCMV virus, showing that HMCV-infected monocyte-derived cells increase the level of cGAMP and type I IFN production in human monocyte-derived DCs and macrophages, while plasmacytoid DCs mount type I IFN responses against HCMV infection in a TLR9-dependent manner. 69 Silencing of RNA polymerase III impairs RIG-I-mediated IFN-b production in exposure to Epstein-Barr virus, HSV-1, and adenovirus, as well as Legionella pneumophila in the RAW264.7 mouse macrophage-like cell line. 12 However, this is opposite to Monroe et al.'s evidence that RNA-sensing pathways via RIG-I and MDA5, instead of the RNA polymerase III DNA sensor, are involved in limiting the replication of Legionella pneumophila in bone marrow-derived macrophages. 122 Likewise, inhibition of RNA polymerase III only partially abolishes IFN-γ-dependent immune response upon exposure to Shigella flexneri DNA. 123 Silencing of RIG-1 and IPS-1 profoundly promotes the growth of Shigella flexneri, suggesting that DNA sensors partially restrict the replication of Shigella flexneri while RNA sensors are crucial in the governing of innate immune responses by sensing Shigella flexneri RNA. 123 Ogunjimi et al. demonstrated that inborn errors in RNA polymerase III promote susceptibility to varicella zoster virus (VZV) infection, which causes varicella (chickenpox) and zoster (shingles). 124 Krug et al. showed that TLR9/MyD88 knockout mice are still capable of restricting HSV-1 replication in vivo even though TLR9/MyD88 is mandatory for inducing type I IFN response in plasmacytoid DCs. 125 It was found that IFN production upon HSV-1 infection is independent of the TLR signaling pathway. 77 Ishikawa et al. reported that the DNA complex from HSV-1 and Listeria monocytogenes induces STING-driven IFN production in murine embryonic fibroblasts, macrophages, and DCs. 81 Impairment of cGAS or STING expression in mice prompts acute HSV-1 encephalitis. 126 High susceptibility with impaired type I IFN production is observed in HSV-1-infected mice and cells in the absence of TRIM56. 74 In addition, Lam et al. demonstrated the involvement of the cGAS-STING signaling pathway in eliciting innate immunity at the onset of other pathogenic infections. The cGAS-STING axis was found to be the dominant intracellular DNA sensor in the intracellular adenovirus in RAW264.7 cells. 127 Song et al. revealed that Helicobacter pylori infection triggers the STING-IRF3 signaling pathway in a mouse model. 128 Upon Plasmodium falciparum parasite infection, which leads to malaria, genomic DNA-harbored extracellular vesicles are released from the infected red blood cells and engulfed by monocytes to produce type I IFN by direct binding to cGAS. This stimulates STING-TBK1-IRF3 signaling. 129, 130 Although Guo et al. reported that the cGAS-STING axis does not have a major role in sensing hepatitis B virus, initiation of the STING signaling pathway in macrophages and hepatocytes promotes the suppression of hepatitis B virus replication, indicating a potential target to be explored in chronic hepatitis B therapy. 131 It has been revealed that the cGAS-STING signaling pathway has a protective effect against Staphylococcus aureus infection. On the other hand, ablation of STING unexpectedly improves antibacterial responses. 132 The immunosurveillance to eliminate this bacterial infection is compensated by TLR signaling, whereby bone marrow-derived macrophages from Myd88/Trif double-knockout mice exhibit a decrement in IL-1β proinflammatory cytokine production and neutrophil infiltration, which favors Staphylococcus aureus growth. 132 Thus, insight is gained into how multiple molecules are involved in governing innate immune responses to provide multiple layers of protection against infection.
Failure in the DNA-sensing pathways lead to pathogen immunosurveillance evasion. Although T-cells sense the DNA of the human immunodeficiency virus via the IFI16 DNA sensor and further activate STING and TBK1, expression of type I IFN and its related genes is absent. 133 Likewise, B-cells that express IFI16, cGAS, TBK1, and IRF3 fail to secrete type I IFN following EpsteinBarr virus infection. 134 This is probably due to the low basal expression of intracellular STING in B-cells. 134 Hence, delivery of exogenous type I IFN, cGAMP, or STING agonists elicited a long-lasting immune response against HIV-1, suggesting a potential new therapeutic concept. 133, 135 On the other hand, Gram et al. revealed that the failure of B-cells in producing type I IFN is not reversed by Epstein-Barr virus-induced STING expression in B-cells. 134 This suggests there might be one or more players in the DNA-sensing pathways that are yet to be discovered.
B. Autoimmune Diseases
A balanced host homeostasis of innate immunity is essential for preventing the development of autoimmune diseases such as Aicardi-Goutieres syndrome (AGS) and systemic lupus erythematosus (SLE). Highly activated innate immune responses accompanied by overproduction of proinflammatory cytokines and type I IFN have been observed in patients with autoimmune disease. Mutation of genes related to the cGAS-STING signaling cascade is commonly found in AGS patients-for instance, TREX1, 136 SAMHD1, 137 ADAR1, 138 and RNase H2. 139 Furthermore, Trex1 deficiency in DCs was found to be sufficient to initiate systemic autoimmunity via stimulation of type I IFN production. 140 Silencing of cGAS in Trex1-or DNase II-deficient mice reduces susceptibility to autoimmune disease by abrogating IFN-induced gene expression. 5, 141 This finding is in line with Ablasser et al.'s in vitro study using STING knockout cell lines, suggesting cGAS participated in inducing an autoimmune response. 142 Mutation of the RNaseH2 enzyme has been found to be associated with excessive cGAS/ STING-mediated IFN-stimulated gene expression, which is seen in AGS patients. 139 Coquel et al. suggested that SAMHD1-deficiency in human cells leads to the release of single-stranded DNA from stalled DNA replication forks into cytosol through MRE11-mediated DNA degradation machinery, resulting in the aberrant activation of the cGAS-STING pathway and the resultant excessive production of type I IFN. 143 SLE is an autoimmune disease that leads to lupus nephritis. Elevated expression of DAI has been detected in SLE patients as well as lupus mice; oligomerization of DAI occurs upon recognition of activated lymphocyte-derived apoptotic DNA, leading to activation of NF-kB and IRF3 signaling pathways. 144 Evidence suggests that STINGactivating mutation also contributes to familial inflammatory syndrome with lupus-like manifestation. 145 A proportion of SLE patients have also been found to have higher expression of cGAS and cGAMP. 146 In addition, patients with STING-associated vasculopathy and pulmonary inflammation demonstrated abnormal increment of STING-IFN pathway. 147 STING has emerged as crucial in governing intestinal immune homeostasis balanced by interaction with the commensal bacteria that modulate the production of anti-inflammatory IL-10 and proinflammatory cytokines. Intestinal dysregulation of this pathway leads to inflammatory bowel disease. 148 Moreover, the continuous release of mitochondrial DNA into the cytosol in conditions of obesity triggers the activation of innate immune responses through the cGAS-STING axis. 94 The cGAS-STING-IRF3 axis is involved in inducing endothelial inflammation as well by sensing metabolic stress-induced mitochondrial DNA induced by palmitic acid. 149 Other DNA sensors such as DNA-PK and IFI16 are significant in autoimmune diseases. Ferguson et al. suggested that DNA-PK deficiency results in severe combined immunodeficiency. 15 Furthermore, excessive circulating IFI16 and anti-IFI16 antibodies have been observed in rheumatoid arthritis patients compared to healthy individuals, implying the engagement of this DNA sensor in regulating rheumatoid arthritis. 6 In the keratinocytes from a patient with psoriasis, a chronic inflammatory skin disease in whose pathogenesis IL-1b plays a central role, AIM2 and IFI16 overexpression was observed along with TBK1-NF-kB signaling pathway activation. 150, 151 Due to the mutation of multiple genes and the complex relationships among DNA signaling pathways, it is mandatory to elucidate the crosstalk between mutated genes. The introduction of inhibitors to suppress excessive activation of innate DNA-sensing pathways might be a potent therapy for autoimmune disease.
C. Cancer Progression
A major hindrance in cancer therapy is tumor evasion of immunosurveillance and impaired adaptive immune responses. Emerging evidence proposes that innate immune pathways such as the DNAsensing pathway are crucial in attenuating the progression of cancer. Low protein expression of STING was detected in tumor tissues from gastric cancer patients and found to be associated with cancer progression and low overall survival. 128 In addition to sensing DNA from pathogenic intruders, the DNA-sensing pathway also detects self DNA, such as dsDNA in micronuclei and single-stranded DNA released by cancer cells.
2 B16 melanoma-derived total DNA stimulates the production of IFN-b in DCs through the cGAS-STING-IRF3 axis. 152 Similarly, the cGAS-cGAMP-STING-IRF3 axis promotes IFN-b and IFN-g cytokine production in the serum of colon tumor-bearing mice; it also promotes mRNA expression in tumor tissue. 153 These studies concluded that the cGAS-STING-IRF3 axis is crucial for activation of DCs to prime CD8+ T-cells in tumor-bearing mice. 152, 153 Extrachromosomal telomere repeat DNA originating in telomeres of cancer cells can trigger the intrinsic intracellular DNA-sensing signaling pathways through both the cGAS-STING-TBK1-IRF3 signaling axis and ATRX, inhibiting proliferation of cancer cells. 154 Impairment of the cGAS-STING DNA-sensing pathway has been detected in alternative lengthening telomere (ALT) cancer cells and found to promote ALT development that results in cancer cell longevity. 154 Mutation of germline or somatic DDX41 contributes to myelodysplastic syndrome or acute myeloid leukemia. 155, 156 Due to the antitumor role of DNA sensors, researchers are targeting these pathways by incorporating associated molecules into DNA vaccination to induce antitumor immunity. TBK1 might be a candidate molecule for accelerating the effect of DNA vaccine, given that in hematopoietic and nonhematopoietic cells it modulates the induction of antigen-specific B-cells as well as CD4+ and CD8+ T-cells, respectively, in response to DNA vaccination. 157 Ishii et al. found that DAI deficiency in mice does not alter IFN-b and IL-6 production in response to B-DNA, suggesting its dispensable role in this aspect. 157 However, Lladser et al. suggested that DAI can be incorporated into DNA vaccine as an adjuvant to potentiate the immune response elicited by cytotoxic CD8+ T-lymphocytes, inducing an antitumor response against B16 melanoma. 158 Zhang et al. also proposed that tumor cell-derived microparticles (consisting of UV-treated tumor cells containing genomic and mitochondrial DNA-loaded DCs can induce DC maturation and thus promote antitumor immunity via the cGAS-STING-type I IFN axis. 159 Cancer cells treated with the anticancer drug topotecan release exosomes containing DNA, which is captured by DCs and activated by them via the STING-IRF3-type I IFN pathway. 160 Moreover, the importance of the STING-dependent DNA-sensing pathway in mounting antitumor immunity has been reported in the case of radiation therapy, which induces type I IFN via STING. 161 Also, cGAMP could work synergistically with fluorouracil, a chemotherapeutic drug, in murine colon 26 adenocarcinoma with lower toxicity in comparison to standalone fluorouracil. 153 In line with this, in a recent in vivo study Wang et al. proposed that cGAS is crucial in controlling B16 melanoma growth and that cotreatment with cGAMP and PD-L1 antibodies yields a synergistic effect in comparison with PD-L1 antibody treatment alone. 162 Nevertheless, Lemos et al. unveiled the dark side of the STING pathway. Once activated, the STING pathway stimulates indoleamine 2, 3-dioxygenase activity in the microenvironment that favors the proliferation of Lewis lung cancer and T-cell evasion in mice characterized with low antigenicity; accordingly, abrogation of STING can enhance the CD8+ T-cell effector function. 163 Furthermore, Bakhoum et al. reported that the cGAS-STING and downstream non-canonical NF-kB signaling are responsible for driving metastasis by sensing the cytosolic DNA generated by chromosomal instability. 164 Due to the complexity of their roles in cancer, a better understanding of the DNA-sensing pathways in cancer and their re-evaluation in the tumor microenvironment are mandatory for developing an effective cancer immunotherapy.
IV. CONCLUSIONS
The underlying mechanisms of intracellular DNA sensors in eliciting innate immune responses against pathogen infections have been strenuously studied. Innate DNA sensors documented so far include TLR9, cGAS, AIM2, IFI16, DAI, RNA polymerase III, DDX41, DHX9, DHX36, MRE11, and DNA-PK, which upon the recognition of DNA ligands induce proinflammatory cytokines and type I IFN production to mount host innate immunity against replication of pathogens as well as stimulate their clearance. However, these sensors detect both non-self and self DNA under certain conditions, such as metabolic stress or cell damage, resulting in autoimmune diseases. DNA-sensing pathways is also involved in regulating insulin resistance and fatty acid-induced inflammation, highlighting the engagement of innate immunity in metabolic aspects. Future research should focus in this area to unveil the underlying roles of DNA-sensing pathway in metabolic-related disease and in so doing better manage it. Moreover, numerous studies have suggested that DNA-sensing pathway-mediated immune responses are cell typespecific. Intracellular DNA can be sensed by multiple DNA sensors. There is increasing evidence of crosstalk among the DNA-sensing pathways, and redundancy of roles might contribute to the loss of function in redundant DNA sensors. How DNA sensors regulate each other is ambiguous. Additional players such as autophagy-related genes seem to be involved. This gives insight into the possibility that one or more candidates in regulating this pathway are yet to be discovered, and therefore the role of individual sensors and the crosstalk between them must be made clear in order to develop an ultimate therapy for infectious as well as autoimmune disease and cancers.
